Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. 1999

D Sankaran, and A Asderakis, and S Ashraf, and I S Roberts, and C D Short, and P A Dyer, and P J Sinnott, and I V Hutchinson
Immunology Research Group, School of Biological Sciences, University of Manchester, England, United Kingdom.

BACKGROUND The proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha) has been implicated in the pathogenesis of acute rejection, while animal models suggest a role for interleukin-10 (IL-10) in promoting graft survival. It has also been shown that polymorphisms in the TNFA gene promoter (position -308) and in the IL-10 gene promoter (position -1082) correlate with differential production of these cytokines in vitro. The aim of this study was to determine whether TNF-alpha and IL-10 gene polymorphisms influence the incidence and severity of acute rejection in the first six months following renal transplantation. METHODS The cytokine genotypes of 115 consecutive first cadaveric kidney allograft recipients and their donors were screened. The rejection episodes (REs) were defined clinically and confirmed histologically where possible and further classified according to severity (RS), namely steroid-resistant or responsive REs. The genotypes were then correlated with the REs and RS. RESULTS The recipient TNF-alpha high producer genotype and IL-10 high producer genotype were significantly associated with multiple REs (>/=2) in human leukocyte antigen (HLA)-DR mismatched transplants (P = 0.0047 and P = 0.045, respectively), whereas only the TNF-alpha high producer genotype was associated with steroid-resistant REs (P = 0.025). When recipient cytokines were analyzed together, the TNF-alpha high/IL-10 high producer genotype had the worst prognosis, whereas TNF-alpha low/IL-10 low producer genotype was protective. CONCLUSIONS We conclude that recipient TNF-alpha and IL-10 gene polymorphisms are determinants of REs and RS following kidney transplantation. Routine screening of these gene polymorphisms may have a clinical role in identifying patients at risk of multiple REs and severe rejections.

UI MeSH Term Description Entries
D011110 Polymorphism, Genetic The regular and simultaneous occurrence in a single interbreeding population of two or more discontinuous genotypes. The concept includes differences in genotypes ranging in size from a single nucleotide site (POLYMORPHISM, SINGLE NUCLEOTIDE) to large nucleotide sequences visible at a chromosomal level. Gene Polymorphism,Genetic Polymorphism,Polymorphism (Genetics),Genetic Polymorphisms,Gene Polymorphisms,Polymorphism, Gene,Polymorphisms (Genetics),Polymorphisms, Gene,Polymorphisms, Genetic
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Sankaran, and A Asderakis, and S Ashraf, and I S Roberts, and C D Short, and P A Dyer, and P J Sinnott, and I V Hutchinson
April 2016, Genetics and molecular research : GMR,
D Sankaran, and A Asderakis, and S Ashraf, and I S Roberts, and C D Short, and P A Dyer, and P J Sinnott, and I V Hutchinson
July 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
D Sankaran, and A Asderakis, and S Ashraf, and I S Roberts, and C D Short, and P A Dyer, and P J Sinnott, and I V Hutchinson
November 2004, Transplantation,
D Sankaran, and A Asderakis, and S Ashraf, and I S Roberts, and C D Short, and P A Dyer, and P J Sinnott, and I V Hutchinson
March 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
D Sankaran, and A Asderakis, and S Ashraf, and I S Roberts, and C D Short, and P A Dyer, and P J Sinnott, and I V Hutchinson
January 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
D Sankaran, and A Asderakis, and S Ashraf, and I S Roberts, and C D Short, and P A Dyer, and P J Sinnott, and I V Hutchinson
June 2019, Transplant immunology,
D Sankaran, and A Asderakis, and S Ashraf, and I S Roberts, and C D Short, and P A Dyer, and P J Sinnott, and I V Hutchinson
April 2008, Molecular and cellular biochemistry,
D Sankaran, and A Asderakis, and S Ashraf, and I S Roberts, and C D Short, and P A Dyer, and P J Sinnott, and I V Hutchinson
November 2008, Pediatric transplantation,
D Sankaran, and A Asderakis, and S Ashraf, and I S Roberts, and C D Short, and P A Dyer, and P J Sinnott, and I V Hutchinson
October 2007, Transplantation,
D Sankaran, and A Asderakis, and S Ashraf, and I S Roberts, and C D Short, and P A Dyer, and P J Sinnott, and I V Hutchinson
May 2005, Transplantation proceedings,
Copied contents to your clipboard!